<DOC>
	<DOCNO>NCT01673360</DOCNO>
	<brief_summary>To monitor post-market performance evaluation short long-term performance via : - Efficacy - Safety - Patient report outcome</brief_summary>
	<brief_title>Collection Long Term Patient Outcomes Data Following Implantation AMS Surgical Devices</brief_title>
	<detailed_description>As post-market registry market approve device , formal hypothesis test . However , point evaluation include : - Characterize efficacy AMS market approve female pelvic health product use standard care outcome measure validate quality life questionnaire - Characterize type , severity , rate adverse event related AMS market approve female pelvic health product - Collect concomitant procedural data relate pelvic floor area</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Patients must meet follow criterion consider inclusion registry . Have sign Informed Consent Form Have sign HIPAA Authorization Form equivalent Patient Privacy Form require outside US Is female least 18 year age Is schedule receive least one ( 1 ) AMS market approve female pelvic health implantable product . Is able willing participate registry Patients exclude registry one follow criterion meet . Patients contraindicate receive target AMS market approve female pelvic health product per product 's IFU</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>vaginal repair</keyword>
	<keyword>urinary sling</keyword>
	<keyword>POP</keyword>
	<keyword>SUI</keyword>
	<keyword>prolapse</keyword>
	<keyword>incontinence</keyword>
</DOC>